Minnesota - August 2022 Archives

ROCHESTER, Minn. — Johnson Memorial Health and Mayo Clinic announced Wednesday, Aug. 31, that the Indiana health system has joined the Mayo Clinic Care Network. ...

ROCHESTER, Minn. — Mayo Clinic researchers have found that using artificial intelligence (AI) algorithms to analyze patterns of changes in women who are in labor ...

ROCHESTER, Minn. — A new type of extravascular implantable cardioverter-defibrillator (ICD) using a lead (thin wire) placed behind the sternum met safety and effectiveness goals ...

ROCHESTER, Minn. — More than 55 million people worldwide are believed to be living with dementia, according to the World Health Organization. Ronald Petersen, M.D., a neurologist and ...

ROCHESTER, Minn. — Mayo Clinic announced today that its Center for Clinical and Translational Science has successfully renewed funding for its research grant from the ...

ROCHESTER, Minn. — A research study of African Americans with cardiovascular disease suggests religious practices and spirituality may contribute to heart health. The study's authors ...

ROCHESTER, Minn. — A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients with ventricular tachycardia, an abnormally rapid heart rhythm ...

ROCHESTER, Minn. — Mayo Clinic Orthopedics and Sports Medicine will provide a Saturday morning injury clinic for Rochester-area middle school, high school and college athletes ...

ROCHESTER, Minn. — As the monkeypox outbreak continues and the U.S. has declared monkeypox a public health emergency, Mayo Clinic experts have published a special article ...

ROCHESTER, Minn. — Researchers from the Mayo Clinic Comprehensive Cancer Center and the Mayo Clinic Center for Individualized Medicine are studying a rare genetic condition ...

ROCHESTER, Minn. — Mayo Clinic today announced a strategic collaboration in biomanufacturing to deliver novel biotherapeutics for rare and complex conditions. The collaboration brings together ...

ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron ...